Pharmaceutical composition comprising (a) a nicotine receptor partial agonist defined, (b) an inhibitor of acetyl or butilcolinesterasa, estrogenic Agent,An Estrogen Receptor Modulator or a agonsita Muscarinic and (c) a vehicle, useful for treating cognitive disorders such as Alzheimer's disease and schizophrenia.

摘要

A Pharmaceutical composition useful in the treatment of Cognitive dysfunction in a Mammal, which contains an inhibitor of acetylcholinesterase,An inhibitor of an agent butilcolinesterasa, estrogen, Selective Estrogen Receptor Modulator or a Muscarinic agonist.Or a pharmaceutically acceptable Salt thereof; and a pharmaceutically acceptable vehicle.The partial agonist nicotine of the receiver and the inhibitor of acetylcholinesterase, inhibitor butilcolinesterasa, estrogenThe Selective Estrogen Receptor Modulator or the Muscarinic agonist are present in quantities that make the effective composition in the potentiation of the Cognition and TreatmentCognitive dysfunction and diseases including, but without imitation, Alzheimer's disease, mild cognitive impairment, age-related Cognitive decline.Vascular dementia, dementia, Parkinson's disease, Huntington's disease, Stroke, bits associated with AIDS Dementia and schizophrenia.